Advances in Brief Implication of Protein Kinase B / Akt and Bcl-2 / Bcl-XL Suppression by the Farnesyl Transferase Inhibitor SCH 66336 in Apoptosis Induction in Squamous Carcinoma Cells 1

Kyung-Hee Chun,Ho-Yyoung Lee,K. Hassan,F. Khuri,W. Hong,R. Lotan
Abstract:The farnesyltransferase inhibitor SCH66336 exhibits antitumor activity in vitro and in vivo; however, its mechanism of action is still unresolved. We found that SCH66336 suppressed growth and induced apoptosis of human head and neck squamous carcinoma cells (HNSCC). SCH66336 suppressed protein kinase B/Akt activity as well as the phosphorylation of the Akt substrates glycogen synthase kinase (GSK)-3 , forkhead transcription factor, and BAD. Infection of SqCC/Y1 cells with an adenovirus that contained a constitutively active form of Akt rescued cells from SCH66336-induced apoptosis. These results suggest that SCH66336 is a potent apoptosis inducer in HNSCC cells and that it may act by suppressing the Akt pathway.
What problem does this paper attempt to address?